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The health benefits of seafood are well documented and based on the unique supply of n-3 35 
highly unsaturated fatty acids (HUFA). Aquaculture now contributes ~50% of food-grade 36 
seafood globally and Atlantic salmon is a rich source of n-3 HUFA. However, salmon and 37 
other oily fish can accumulate lipophilic persistent organic pollutants (POPs), including 38 
dioxins (PCDD/Fs), polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers 39 
(PBDEs), derived largely from feed. In this study, triplicate groups of salmon, of initial 40 
weight 0.78 kg were fed one of three experimental diets for 11 weeks. The diets were coated 41 
with either a northern fish oil (FO) with a high POPs content (cNFO), the same oil that had 42 
been decontaminated (deNFO) or a blend of southern fish oil, rapeseed and soybean oils 43 
(SFO/RO/SO). Dietary PCDD/F + dioxin-like PCB (DL-PCB) concentrations were 17.36, 44 
0.45 and 0.53 ng TEQ/kg, respectively. After 11 weeks, the flesh concentrations in fish fed 45 
the cNFO, deNFO and SFO/RO/SO diets were 6.42, 0.34 and 0.41 ng TEQ/kg, respectively. 46 
There were no differences in flesh eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) 47 
between fish fed the cNFO or deNFO diets although EPA and DHA were reduced by 50 and 48 
30%, respectively, in fish fed the SFO/RO/SO diet. Thus, decontaminated FO can be used to 49 
produce salmon high in n-3 HUFA and low in POPs. Salmon produced using deNFO would 50 
be of high nutritional value and very low in POPs and would utilise valuable fish oils that 51 
would otherwise be destroyed due to their high pollutant concentrations.  52 
















In the 1970s, studies on Greenland Inuit populations established that, despite consuming high 68 
lipid diets, cardiac disease was virtually absent in these populations and that this was due to 69 
their high fish intake(1). Subsequently, the beneficial effects of n-3 highly unsaturated fatty 70 
acids (HUFA), especially eicosapentaenoic (20:5n-3; EPA) and docosahexaenoic acids 71 
(22:6n-3; DHA) have been shown to have cardioprotective activity(2,3). More recently, the 72 
benefits of increased EPA and DHA intake have been shown for a wide range of lifestyle 73 
disorders with an associated inflammatory pathology(4,5) as well as improving the symptoms 74 
of certain neurological disorders(6). Due to the proven benefits of n-3 HUFA, numerous 75 
governmental and non-governmental organisations across the world currently advise 76 
increased fish intake as a means of improving the health of their citizens(7,8).  77 
Atlantic salmon can store large quantities of oil in their flesh and this makes them a rich 78 
source of n-3 HUFA(9,10). However, the oil-rich flesh can also accumulate lipophilic 79 
undesirable compounds, including polychlorinated dibenzo-p-dioxins (PCDD) and 80 
polychlorinated dibenzofurans (PCDF) (collectively known as dioxins or PCDD/F), dioxin-81 
like non-ortho and mono-ortho polychlorinated biphenyls (PCBs), known collectively as 82 
dioxin-like (DL) PCBs and polybrominated diphenyl ethers (PBDEs), among 83 
others(11,12,13,14,15). For these reasons there is currently considerable interest to investigate the 84 
transfer of persistent organic pollutants (POPs) from feed to farmed fish as well as assessing 85 
the potential for transfer to humans and any consequences for human health(16,17).   86 
There are 210 dioxin (75 PCDD & 135 PCDF congeners) and 209 PCB congeners of 87 
which 17 PCDD/PCDF congeners and 12 DL-PCBs have been assigned toxic equivalency 88 
factors (TEFs) by the World Health Organisation (WHO), according to their relative toxicity 89 
to 2,3,7,8 tetra chlorinated dibenzo dioxin (TCDD). The concentration of PCDD/F and DL-90 
PCB is expressed as toxic equivalents (TEQ), where a toxic equivalency factor (TEF) is 91 
applied to the concentration of the individual congeners and summed to generate the total 92 
TEQ in a mixture of the 29 PCDD/F and DL-PCB congeners. The TEFs established in 1997 93 
by the World Health Organisation have been most widely used for human risk assessment by 94 
government bodies(18), these TEFs were re-evaluated in 2005(19). Application of these factors 95 
to individual PCDD/F and DL-PCB congener concentrations in a feed or fish can be used to 96 
determine the level of toxic equivalents (TEQs) present. PCDD/Fs and PCBs have originated 97 
either by natural means, such as forest fires and incomplete combustion  (dioxins), or by 98 
industrial activity (PCDD/F and PCBs) and both have half-lives of several decades and are 99 
highly persistent in the marine biota(20).  100 
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In addition to PCDD/Fs and PCBs, the PBDEs are of more recent origin, having been 101 
introduced as flame retardants in household furnishings, computers and electrical circuits 102 
since the 1970s(12). As with PCDD/Fs and PCBs, PBDEs are lipophilic and accumulate in the 103 
aquatic biota and humans(12,21) although at the present time no TEQs have been assigned for 104 
any PBDE congeners. Although there are 209 possible PBDE congeners, only a few are 105 
present in commercial mixtures and those are represented in tissues by 7 principal congeners 106 
namely PBDE 28, 47, 99, 100, 153, 154 and 183(21).  107 
Within the European Union, limit values for PCDD/Fs were established in 2001, which 108 
were revised in 2006 to include concentrations of all 29 PCDD/Fs and DL-PCB congeners 109 
assigned WHO TEFs(22,23). These limit values cover raw materials, feeds and fish products. 110 
The current EU limit values are 24 ng, 4.5 ng, 7 ng and 8 ng TEQ/kg, for fish oil, fish meal, 111 
fish feed and fish products, respectively. The main contributor to POPs in fish feeds and fish 112 
is fish oil (FO) derived from pelagic marine fish(24). In recent years a number of studies have 113 
been conducted where FO was replaced by terrestrial vegetable oils (VO) in salmon 114 
feeds(9,10,14,15). The fish produced using diets with a high VO content contained significantly 115 
lower levels of POPs compared to fish grown on diets with a high marine FO content(14,25). 116 
However, the reduction in POPs was accompanied by reductions in EPA and DHA of 50-117 
65%, which would obviously reduce the health benefits of this product to the consumer(14,15). 118 
With the introduction of the revised EU limits for PCDD/Fs and DL-PCBs in 2006, some of 119 
the FOs previously used in aquafeeds would no longer comply with these new limits and so 120 
would have to be removed from the food chain. The loss of valuable n-3 HUFA in this way, at 121 
a time when FO have reached their sustainable production limits and prices are rising rapidly, 122 
is a major dilemma and has increased the desire to develop technology to clean FO of POPs 123 
so that they might be used in aquafeeds(26,27).  124 
The aim of the present study was to investigate the effects on tissue POPs concentrations 125 
of replacing northern FO, containing high levels of POPs, with either the same oil which had 126 
been cleaned using a decontamination protocol or a blend of southern FO, soya and rapeseed 127 
oils (4:3:3 by volume). The 3 diets were fed to triplicate groups of Atlantic salmon in sea 128 
cages for a period of 11 weeks. The effects of these 3 treatments on PCDD/F, DL-PCB, 129 
PBDE and n-3 HUFA concentrations in fish feed and flesh are presented. 130 
 131 
Materials and methods 132 
 133 
Fish, husbandry and diets 134 
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Three 9 mm extruded diets were prepared with the same basal composition, but were top 135 
coated with 3 different oils and were prepared at the BioMar Tech Centre, Brande, Denmark 136 
(Table 1). The diets were formulated to satisfy the nutritional requirements of salmonid 137 
fish,(28) and contained 33% protein and 34% lipid. The three diets contained either a) 100% 138 
northern FO (cNFO) as control, b) 100% decontaminated northern FO (deNFO), and c) a 139 
blend of southern FO and rapeseed and soya oil in a ratio of 40/30/30; (SFO/RO/SO). The 140 
deNFO was the same product and batch as the cNFO following the decontamination process. 141 
The cNFO was selected to contain high levels of POPs and this oil was subjected to a two-142 
stage decontamination process (FF Skagen, Denmark) that involved an initial adsorption 143 
using activated carbon that was designed to remove ~90% of the PCDD/Fs. The second step 144 
was a thin-film deodourisation step that should remove up to 95% of PCBs as well as 145 
pesticides and other contaminants, free fatty acids and peroxides. The deNFO oil was 146 
representative of decontaminated oil currently commercially available in Europe. Atlantic 147 
salmon of initial mean weight 0.78 ± 0.01 kg were fed one of the three experimental diets for 148 
11 weeks in 9 x 5 m3 net pens containing 120 fish/pen at the Fjord Research Station, Dønna, 149 
Norway. The experiment was conducted between July and October 2006 under ambient 150 
photoperiod and the mean seawater temperature was 11.5 ± 2.7 oC and salinity 31.9 ± 0.8 ppt. 151 
Feed was supplied manually to apparent satiation with waste feed collection provided by an 152 
uplift system. Experimental procedures complied with the Norwegian code of practice for the 153 
care and use of animals for scientific purposes and there are no aspects of this trial that would 154 
cause aggravated or unnecessary harm or stress to the fish involved. 155 
 156 
Sample collection 157 
Samples of the three feeds were collected at the start of the trial and wrapped in foil before 158 
placing in sealable polythene bags and storing at -20oC. Samples of fish were collected at the 159 
start and end of the trial with 3 fish per pen (9 per dietary treatment) anaesthetised by 160 
metacaine (50 mg/L) and then killed by a blow to the head. Samples of flesh from the 161 
Norwegian Quality Cut (NQC) region were collected, wrapped in foil and immediately frozen 162 
at -20oC and transported to the laboratory where they were stored at -70oC until analysed. The 163 
samples were selected from fish that were close to the average fish weight in each pen. The 164 
three NQC samples from each pen were then pooled, to provide three samples per treatment 165 
group. Before analysis, the pooled steaks were homogenised in a food processor after removal 166 
of skin and bones. Samples of these homogenates were used for POPs and fatty acid analyses.  167 
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 168 
Analysis of PCDD/Fs, DL-PCBs and PBDEs  169 
Homogenised samples of wet flesh (~50g) were freeze dried for minimum 12 h before 170 
extraction. Samples of diet (~10g) were weighed as above and ground in a coffee grinder 171 
prior to extraction. The entire flesh and diet samples were extracted using isohexane in an 172 
accelerated solvent extractor (ASE™, Dionex, Camberley, UK). Each sample was accurately 173 
weighed, mixed with hydromatrix (Varian Inc., USA) before addition of 1ml of a 2 ng.ml-1 174 
13C-labelled PCDD/F and PCB internal standard (EPA-1613-LCS; Wellington Laboratories, 175 
Guelph, Cananda).  Samples were extracted by ASE™ for 20 minutes x 2 cycles with 176 
isohexane under pressure (1500 psi) and temperature (125oC). Fat and organic matter were 177 
removed from the 120 ml ASE™ extract by sulphuric acid treatment. Fifty ml of 95-97% 178 
sulphuric acid was added to the lipid extract in a separation funnel and left for 72h. The 179 
sulphuric acid was drained off and the organic phase washed with 50 ml of nanopure water 180 
(Millipore UK Ltd., UK) and left for 3 h.   181 
Clean-up of the extracted lipid samples was then performed using the automated multi-182 
column Power-Prep™ System (Fluid Management Systems, Waltham, MA, USA) using a 183 
series of disposable teflon columns of multi-layered silica (4 g acid, 2 g base and 1.5 g 184 
neutral), basic alumina (8 g) and carbon (2 g).  For high lipid samples, high capacity silica 185 
columns (28 g acidic, 16 g basic and 6 g neutral) were used.  The total run time was 150 min 186 
followed by a 40 min preventative decontamination programme.  The mono-ortho PCBs were 187 
collected in 120 ml isohexane-dichloromethane (1:1 v/v) and the PCDD/F and non-ortho 188 
PCBs eluted in 120 ml toluene.  The purified fractions were evaporated to ~5 ml by rotary 189 
evaporation (Rotavapor® R-200; Büchi Ltd, Oldham, UK) in a heated water bath set at 25oC 190 
and 320 mbar pressure for mono-ortho PCBs and 40oC and 70 mbar pressure for PCDD/F and 191 
non-ortho PCBs.  The mono-ortho PCB fraction was evaporated to dryness under nitrogen (N-192 
Evap™111; Organomation Associates Inc., Massachusetts, USA) at room temperature before 193 
5 ml isohexane and 5 ml concentrated sulphuric acid was added, vortex mixed, and 194 
centrifuged (5 min, 478 g).  The organic phase was transferred to a clean conical tube and 195 
evaporated to approximately 1 ml under nitrogen before addition of 1 ml isooctane and further 196 
evaporation to 500 µl.  The sample was finally transferred to a conical GC vial containing 150 197 
µl of nonane as the keeper and evaporated to 100 µl prior to analysis by GC/MS/MS. 198 
The PCDD/F and non-ortho PCB fraction was evaporated to 500 µl under nitrogen and 199 
transferred to a conical GC vial containing 60 µl of nonane before further evaporation to 10 µl 200 
where 400 µl of isohexane and 10 µl of recovery standard (EPA-1613-ISS for PCDD/F and 201 
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68A-IS for PCBs; Wellington Laboratories, Guelph, Canada) was added and vortex mixed.  202 
Thirty-five µl of sulphuric acid was added to the vial, vortex mixed and left for 1 hour before 203 
centrifugation (5 min, 1328 g).  The organic phase was transferred to a clean conical GC 204 
autosampler vial containing 10 µl of nonane as keeper and evaporated to 10 µl or 50 µl level 205 
prior to analysis by GCMS for PCDD/F or non-ortho PCB analysis respectively. 206 
 Analysis of the 29 PCDD/F and DL-PCB congeners with WHO TEFs was conducted using 207 
GC/MS/MS on a Trace GC 2000 coupled to a Polaris Q ion trap MS/MS (Thermo Finnegan, 208 
Hemel Hempsted, England). The chromatographic separations were conducted on a Rxi-5ms 209 
(5% phenyl/95% dimethyl polysiloxane) fused silica column (Thames Restek Ltd., 210 
Saunderton, England) 30 m x 0.25 mm i.d. x 0.25 mm film thickness with helium as carrier 211 
gas at 0.8 ml/min. Injector temperature was kept at 250oC and samples and standards were 212 
injected in the splitless mode. MS conditions were in positive electron ionisation mode (EI+) 213 
using automatic gain control with electron energy of 70eV and emission current of 250 µA. 214 
The transfer line and ion source were kept at 305 and 250oC respectively. Xcalibar version 1.3 215 
software was used for data acquisition and processing of results. The limit of quantification 216 
(LOQ), which was determined by using 9 times the background level (3 x limit of detection; 217 
LOD in the blanks of each congener. Procedural blanks were run for each batch of up to ten 218 
samples. Each batch of samples were analysed with one procedural blank, one external QC 219 
sample and one internal QC sample. The external QC was cod liver oil (Food Analysis 220 
Performance Assessment Scheme®, CSL, York, England; T0623) and the internal QC was 221 
internally validated salmon flesh. Percentage recoveries were in the range 78-114%. 222 
Quantification of each congener is based on the isotope dilution method of the USEPA 223 
methods 1613 and 1668(29,30). The range of LOQs for whole fish sample were 0.03-0.18 pg g-1 224 
wet weight for PCDD/Fs, 0.03-0.06 pg g-1 wet weight for non-ortho PCBs and 0.03-0.06 pg g-225 
1 wet weight for mono-ortho PCBs. The congeners analysed included the 17 PCDD/Fs and 12 226 
DL- PCBs for which the World Health Organization has established toxicity equivalent 227 
factors, TEFs from 1997(18) and recently re-evaluated TEFs(19) (Table 2).  228 
 229 
Analysis of PBDEs 230 
For PBDE analysis, 25 g of homogenised wet flesh were freeze dried as described above. 231 
The dried flesh sample or 10 g of diet were ground by mortar and pestle or coffee grinder, 232 
respectively, and 2.5 g of flesh or diet was extracted using the ASE™ extraction cell 233 
containing 19 g silica gel-sulphuric acid mixture (1:1 wt/wt) and hydromatrix before addition 234 
of 20 µl of a 500 ng.ml-1 PBDE-119 internal standard (Wellington Laboratories, Guelph, 235 
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Canada). Samples were extracted by ASE for 20 minutes x 2 cycles with dichloromethane-236 
isohexane (4:1 v/v) under pressure (1500 psi) and temperature (40oC). The extracts from the 237 
ASE™ was reduced to ~5ml by rotary evaporation at 30oC and 320 mbar and then reduced to 238 
1ml under nitrogen at room temperature. Five ml of isohexane and 2ml of concentrated 239 
sulphuric acid were added, vortex mixed and centrifuged (15 min, 1328g). The organic phase 240 
was transferred to a clean tube and the procedure repeated. The combined organic phases 241 
were reduced to 1ml under nitrogen and 100µl of concentrated sulphuric acid added, mixed 242 
and centrifuged (4 min, 212g). The isohexane layer was then transferred to a silanized GC 243 
autosampler vial containing 500 µl of nonane as the keeper and the solvent evaporated under 244 
nitrogen to the nonane mark prior to analysis by GC/MS. 245 
 Analysis of the seven PBDE congeners (28, 47, 99, 100, 153, 154 & 183) was conducted 246 
using a Thermo Finnegan Trace GC Ultra equipped with a ZB5-MS column (30m x 0.25 mm 247 
i.d. x 0.25 micron phase; Phenomenex, Macclesfield, England) using helium as carrier gas 248 
coupled to a Trace DSQ MS, (Bremen, Germany) in negative chemical ion (CI-) mode and 249 
methane as reagent gas at a flow rate of 2.0 ml/min. The mass spectrometer was operated in 250 
the selective ion monitoring mode at the m/z = 79 and 81. Procedural blanks were the same as 251 
described for PCDD/F + DL-PCBs above. The external QC was supplied by the Norwegian 252 
Institute of Public Health and the internal QC was internally validated salmon flesh. Xcalibar 253 
version 1.4 software was used for data acquisition and processing of results. The range of 254 
limits of quantification for whole fish sample were 2-63 pg g-1 wet weight for PBDEs. 255 
 256 
Lipid content and fatty acid compositions 257 
Total lipid was extracted from 1 g of diet or flesh homogenates by homogenising in 20 258 
volumes of ice-cold chloroform/methanol (2:1, v/v) using an Ultra-Turrax tissue disrupter 259 
(Fisher Scientific, Loughborough, U.K.). The total lipid fraction was prepared according to 260 
the method of Folch et al(31) with non-lipid impurities removed by washing with 0.88% (w/v) 261 
KCl. The lipid weight was determined gravimetrically after evaporation of solvent under 262 
nitrogen and desiccation in vacuo for at least 16h.   263 
Fatty acid methyl esters (FAME) were prepared from diet and flesh total lipid by acid-264 
catalysed transesterification according to the method of Christie(32). Extraction and 265 
purification of FAME was performed as described by Tocher and Harvie(33). FAME were 266 
separated and quantified by GC (Carlo Erba Vega 8160, Milan, Italy) using a 30 m x 0.32 mm 267 
i.d. x 0.25 mm film thickness capillary column (CP Wax 52CB, Chrompak, London, U.K.) 268 
and cold on-column injection. Hydrogen was used as carrier gas and temperature 269 
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programming was from 50oC to 150oC at 40oC min-1 and then to 230oC at 2.0oC min-1. 270 
Individual methyl esters were identified by comparison with known standards and by 271 
reference to published data(33,34). Data were collected and processed using the Chromcard for 272 
Windows (version 2.01) computer package (Thermoquest Italia S.p.A., Milan, Italy). 273 
 274 
Statistical analysis 275 
Significance of differences (P < 0.05) between dietary treatments was determined by one-way 276 
ANOVA. Differences between means were determined by Tukey’s test. Data identified as 277 
non-homogeneous, using Bartlett’s test, were subjected to log or arcsin transformation before 278 
applying the ANOVA. ANOVA was performed using a GraphPad Prism (version 4.0) 279 
statistical package (GraphPad Software, San Diego, CA, USA.  280 
 281 
Results 282 
The fish grew from an initial weight of 0.78 kg to 2.19 kg over the 11 week trial and there 283 
were no significant differences in final weights between the three treatments. Specific growth 284 
rate (SGR; %/day) values were in the range 1.34-1.35 and Thermal Growth Coefficient 285 
(TGC) between 3.86 and 3.92 while the Feed Conversion Ratio (FCR) values were in the 286 
range 0.96-0.98. There were no differences between treatments and all these values were 287 
comparable with normal commercial practice for salmon of this size and culture conditions.  288 
The cNFO diet contained 17.4 ng TEQ/kg of the 29 WHO PCDD/F and DL-PCB 289 
congeners with assigned TEFs (Table 2). This value is significantly higher than the EU limit 290 
for fish feeds of 7 ng TEQ/kg(22). However, following the two-step decontamination of the 291 
cNFO oil, this value was reduced to 0.45 ng TEQ/kg in the deNFO diet that was comparable 292 
to the value of 0.53 ng TEQ/kg in the SFO/RO/SO blend diet (Table 2). These values 293 
represent 6.3 and 7.6% of the EU limit, respectively(22), and indicate that the decontamination 294 
process was successful. When comparing the POPs concentrations in the 3 diets, a reduction 295 
of PCDD/Fs of 97% was observed for both the deNFO and SFO/RO/SO diets compared to the 296 
cNFO diet. Similarly, an overall 98% reduction of both mono-ortho and non-ortho PCBs was 297 
noted compared to the cNFO diet with individual congeners being reduced by 71-99% and 298 
93-99%, respectively (Table 2).  299 
The sum concentrations of the 7 PBDE congeners in diets were 5.9, 1.9 and 0.31 ng/g wet 300 
weight, for the cNFO, deNFO and SFO/RO/SO diets, respectively (Table 3). The sum PBDEs 301 
were reduced by 68% for the deNFO compared to the cNFO diet, and 95% for the 302 
SFO/RO/SO, compared to the cNFO diet. The individual PBDE congeners were reduced by 303 
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35-94% in the deNFO diet and by 93-100% in the SFO/RO/SO diet compared to the cNFO 304 
diet (Table 3).  305 
In the initial fish at the start of the trial, the sum of flesh PCDD/Fs + DL-PCBs was 1.06 ng 306 
TEQ/kg (Table 4). In fish fed the cNFO diet for 11 weeks this value increased significantly to 307 
6.42 while in fish fed the deNFO and SFO/RO/SO diets the concentrations were significantly 308 
reduced to 0.34 and 0.41, respectively, compared to the initial fish (Table 4). The flesh 309 
concentration for the fish fed cNFO was however below the EU limit value of 8 ng TEQ/kg 310 
while the deNFO and SFO/RO/SO flesh represented 4.3 and 5.1% of the EU limit value, 311 
respectively(23). 312 
In the initial fish flesh at the start of the trial, the sum concentration of the 7 PBDE 313 
congeners was 0.26 ng/g wet weight. After feeding the experimental diets for 11 weeks the 314 
flesh value in fish fed the cNFO diet increased significantly to 0.94 ng/g, while fish fed the 315 
deNFO diet had similar levels to the initial fish of 0.25 ng/g and fish fed the SFO/RO/SO diet 316 
had a significantly reduced concentration of 0.095 ng/g, compared to the initial flesh (Table 317 
5). The sum PBDEs were reduced by 73% for the deNFO compared to the cNFO diet and 318 
90% for the SFO/RO/SO compared to the cNFO diet.  319 
Flesh total lipid content increased from 9.0 ± 0.9% in initial fish to 17.0 ± 1.6% in the final 320 
fish. There were no differences between treatments. Flesh fatty acid levels were closely 321 
correlated to dietary values and DHA values were similar for fish fed the cNFO and deNFO 322 
diets although EPA was significantly higher in the latter (Figure 1). By contrast, the DHA and 323 
EPA values in the flesh of fish fed the SFO/RO/SO diet were significantly lower than in the 324 
two FO groups, being reduced by 50 and 30%, respectively (Figure 1). At the same time fish 325 
fed the SFO/RO/SO diet had increased levels of linoleic (18:2n-6 and linolenic acids (18:3n-326 
3) of 3.6 and 2-fold, respectively (Figure 1).  327 
Data presented from this study shows that consumption of 2 x 140g portions of cNFO 328 
salmon would represent 171% of the weekly limit for PCDD/Fs + DL-PCBs for girls and 329 
women of reproductive age(35) (UK Food Standards Agency (FSA); www.food.gov.uk) 330 
(Figure 2) 140g portions are the standardised portion sizes used by the FSA. However, this 331 
value assumes that salmon is the only dietary input of PCDD/Fs and DL-PCBs while in 332 
practice the 2 x 140g portions would contribute to more than 171% of the weekly limit due to 333 
consumption of other food products that also contain POPs, albeit at a lower level than that 334 
seen in the cNFO salmon. In the UK, as in most countries in the developed world the largest 335 
contribution to weekly POPs intake is derived from dairy products(4). Consuming 4 x 140g 336 
portions would represent 86% of the FSA weekly limit value for boys, men and women over 337 
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reproductive age. By comparison, consuming 2 x 140g portions of salmon fed the deNFO or 338 
SFO/RO/SO diets represents 9.0 and 10.8%, respectively, of the weekly limit for girls and 339 
women of reproductive age while consuming 4 x 140g portions represents 4.5 and 5.4%, 340 
respectively of the weekly limit for PCDD/Fs + DL-PCBs for boys, men and women over 341 
reproductive age (Figure 2). Over the years many advisories have been issued on guideline 342 
intakes for EPA and DHA in humans(4,7,8). The intake advice of the International Society for 343 
the Study of Fatty Acids and Lipids (ISSFAL) is for a daily intake of EPA + DHA of 500 mg 344 
or 3.5g/week(8). Thus, 2 x 140 g portions of salmon fed the cNFO, deNFO and SFO/RO/SO 345 
diets provides 4.81 5.14 and 2.83 g EPA + DHA, respectively, while 4 x 140 g portions 346 




The cNFO diet used a sprat oil from the Baltic Sea that was selected to be high in POPs and 351 
this same oil was subjected to the two step decontamination process at Skagen FF to produce 352 
the deNFO oil. Previously, removal of > 90% of PCDD/F from FO could be achieved using 353 
activated carbon treatment alone. However, removal of DL-PCBs was less effective and 354 
required the use of high temperature deodourisation that could cause oxidation of HUFA(26,36).  355 
More effective removal of both PCDD/Fs and DL-PCBs can be achieved using activated 356 
carbon coupled with short path distillation as has been used in the present study(27). Other 357 
methods for removal of POPs from FO are being developed, including supercritical CO2 358 
extraction along with activated carbon(37). However, this methodology is equally efficient but 359 
has only been used in relatively small scale extractions at the present time. 360 
The cNFO diet in the present study contained 17.4 ng TEQ/kg of PCDD/Fs + DL-PCBs 361 
and, as such, exceeds the EU maximum permitted value of 7.0 ng TEQ/kg for fish feeds(22). 362 
Fish oils are generally considered to be the major source of PCDD/Fs and DL-PCBs in high 363 
energy fish diets although a smaller contribution is derived from the fish meal 364 
component(14,15,24,39). Despite there being considerable variation in contaminant concentrations 365 
in northern FO, due to season and location of capture, they are generally higher in PCDD/Fs 366 
and DL-PCBs compared to those of Pacific origin(40,41).  As a result of high POPs levels, a 367 
significant tonnage of FO from the North Atlantic, North and Baltic Seas would currently 368 
exceed EU permissible limits for PCDD/Fs + DL-PCBs.  Currently, oils such as the cNFO 369 
used in the present study could not be used in animal feeds and would be destroyed by high 370 
temperature incineration. Given the nutritional value of n-3 HUFA as a beneficial nutrients to 371 
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attenuate a range of inflammatory disorders in humans(6,42), and the fact that FO prices 372 
exceeded $1700/tonne in January 2008, it seems wasteful to dispose of valuable nutrients in 373 
this way. The decontamination of the cNFO was very successful with the dietary 374 
concentration of PCDD/Fs + DL-PCBs falling by 97% in the deNFO diet, which was similar 375 
to the concentration of 0.53 ng TEQ/kg in the SFO/RO/SO diet. This reduction in PCDD/Fs 376 
and DL-PCBs, indicates that the efficiency of the decontamination process was consistent 377 
with reports in the literature(26,43).  378 
Hites et al.(11) reported PCDD/Fs + DL-PCBs in Scottish farmed salmon feeds in the range 379 
2.5-7 ng TEQ/kg with lowest values ~1 ng TEQ/kg in feed from Canada. Both the deNFO and 380 
SFO/RO/SO diet in the present study had lower levels of PCDD/Fs + DL-PCBs compared to 381 
the Canadian feeds sampled in 2003/04. Easton et al., (2002) sampled five feeds from North 382 
America and found concentrations for DL-PCBs alone in the range 1.73-10.9 ng TEQ/kg. The 383 
highest concentration found by Easton et al.,(38) was similar to the DL-PCB concentration in 384 
the cNFO diet (8.71) while the concentrations in the deNFO and SFO/RO/SO diets were 83% 385 
lower than the lowest diets sampled from North America. This clearly demonstrates the value 386 
of using either a decontaminated FO or a FO/VO blend as a means of reducing feed 387 
contaminant levels. The contaminant concentrations found in the present study, in the deNFO 388 
and SFO/RO/SO diets, are broadly similar to those seen in previous studies where FO has 389 
been substituted, partially or completely, with VO(14,15,25). In a study where salmon were fed 390 
diets containing either 17 or 34% oil, which was a 100% replacement of FO with a blend of 391 
rapeseed and linseed oils, the PCDD/F + DL-PCB concentrations in the diet were 0.95 and 392 
0.78 ng TEQ/kg, respectively(25). These values are about double those in the deNFO and 393 
SFO/RO/SO diets used in the present study. These differences probably reflect the use of 394 
northern fish meal in the study of Bell et al.,(25) compared to southern fish meal in the present 395 
study. Two similar studies using different levels of FO substitution were conducted by 396 
Berntssen et al.(13,14) In the first trial, fish were fed 100% northern FO or 100% of a VO blend 397 
comprising RO, linseed and palm oils for the whole production cycle. As FO content 398 
increased with pellet size the PCDD/F + DL-PCB in ng TEQ/kg feed increased from 2.43 in 399 
the 0.3 mm pellet to 4.74 in the 9 mm pellet(14). In the VO diet, as the VO inclusion increased 400 
with pellet size, the PCDD/F + DL-PCB in ng TEQ/kg reduced from 1.07 in the 0.3 mm pellet 401 
to 0.61 and 0.33 in the 6 and 9 mm pellets. Thus, the values for PCDD/Fs + DL-PCBs 402 
recorded in the present study, for the deNFO and SFO/RO/SO diets of 0.447 and 0.533 ng 403 
TEQ/kg, respectively, were broadly similar to the 100% VO diets used by Berntssen et al(14). 404 
In a second study where 100% southern FO was replaced with 30% or 60% RO, the diet 405 
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concentrations of PCDD/Fs + DL-PCBs were 1.18, 0.93 and 0.86 ng TEQ/kg, respectively(13). 406 
The value of 0.86 is slightly higher than for the SFO/RO/SO diet of 0.53 ng TEQ/kg, which 407 
was also a 60% replacement with VO. 408 
The reduction of PBDEs in the deNFO diet, compared to the cNFO diet, was 73%, while 409 
the SFO/RO/SO diet had a 90% reduction compared to the cNFO diet, which suggested less 410 
efficient removal of PBDEs compared to dioxins and PCBs. However, use of activated carbon 411 
alone did not reduce PBDE levels in FO(43) and so the addition of the short-path distillation 412 
step resulted in a significant reduction in PBDEs in the deNFO diet. However, the 413 
decontamination method used in the present study is less efficient for PBDEs than for 414 
PCDD/Fs and DL-PCBs. In four samples of feed from Scotland, Hites et al.,(12) reported total 415 
PBDE concentrations in the range 2.44-10.9 ng/g wet weight while in 6 samples from Canada 416 
the range was 0.49-9.3. By comparison Easton et al.,(38) measured two North American feeds 417 
which contained 1.87 and 1.90 ng/g. It is noteworthy that the sum PBDEs for 3 of the Scottish 418 
diets and 2 of the Canadian diets(12) were higher than the value of 5.94 ng/g observed in the 419 
cNFO diet. By comparison, the PBDE concentration in the deNFO diet of 1.93 ng/g is lower 420 
than 9 of the feeds from Scotland, Canada and Chile analysed by Hites et al.,(12) and similar to 421 
the two feeds analysed by Easton et al(38). The sum PBDE in the SFO/RO/SO diet was 0.31 422 
ng/g, and was lower than any value reported by either Hites et al.,(12) or Easton et al(38).  423 
In the present study, the PCDD/F and DL-PCB concentrations in flesh were closely 424 
correlated with diet concentrations with highest values in fish fed the cNFO diet (6.4 ng 425 
TEQ/kg). This value was increased compared to the initial flesh (1.1 ng TEQ/kg) but was 426 
much lower than the diet concentration. This was also observed in previous studies with 427 
salmon where the accumulation efficiency of PCDD/Fs was shown to be lower than for DL-428 
PCBs(13,14). In comparison to the fish fed the cNFO diet, the PCDD/F + DL-PCB 429 
concentrations in flesh of fish fed the deNFO and SFO/RO/SO diets were decreased 430 
compared to the initial values to 0.34 and 0.41, respectively. Although there are no data in the 431 
literature on effects of feeding decontaminated oils, values are reported for fish fed varying 432 
levels of VO, as well as different sources of FO. In the study by Bell et al.,(25) flesh PCDD/F 433 
+ DL-PCB concentration in salmon fed a similar oil level to the present study, but where the 434 
VO was 50% RO and 50% linseed oil, was 0.73 ng TEQ/kg, which was more than double the 435 
values seen in the fish fed deNFO and SFO/RO/SO in the present study. Despite having a 436 
higher level of VO, this higher value is probably due to the use of northern fish meal in the 437 
2005 study. The concentrations in the study by Bell et al.,(25) are similar to those found by 438 
Berntssen et al.,(13) who reported values of 0.95 and 0.86 ng TEQ/kg for fish fed either 30% 439 
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or 60% RO, respectively. The sum ng TEQ/kg for fish fed the deNFO and SFO/RO/SO diets, 440 
in the present study, were 0.34 and 0.41, respectively. These values are similar to the results 441 
reported by Berntssen et al.,(14) where salmon were fed a 100% VO oil inclusion for 97 442 
weeks. Although the fish in the present study were harvested at a smaller size than those 443 
produced by Berntssen et al.,(14) it is likely that the values would decrease even more with 444 
continued culture on the deNFO and SFO/RO/SO diets. The present study lasted for only 11 445 
weeks, while the half-life of PCDD/Fs and DL-PCBs is estimated at approximately 5 446 
months(13), and an additional growth dilution would cause a continued lowering of POP loads. 447 
Thus, a further decrease in PCB levels, at least, would be expected with continued feeding on 448 
deNFO and SFO/RO/SO diets.  449 
In the study of Hites et al.,(11) PCDD/F + DL-PCB concentrations for Scottish salmon were 450 
~2.9 ng TEQ/kg (n = 30) while the concentrations in fish fed the deNFO and SFO/RO/SO 451 
diets were around 13% of this value. In a more recent study Ikonomou et al.,(44) recorded a 452 
maximum value of 1.85 ± 0.27 ng TEQ/kg in Canadian salmon. By comparison the fish fed 453 
the deNFO and SFO/RO/SO diets were ~20% of this value. The mean feed PCDD/F + DL-454 
PCB value in the Canadian diets was 3.74 ng TEQ/kg(44) which is 7.5 times higher than the 455 
deNFO and SFO/RO/SO diets in the present study. The PCDD/F + DL-PCB concentration for 456 
wild Pacific Chinook salmon was ~0.13 ng TEQ/kg(11) while the DL-PCB values alone for a 457 
different source of Chinook salmon were ~0.45 ng TEQ/kg(38). Thus, the PCCD/F + DL-PCB 458 
concentrations in fish fed the deNFO and SFO/RO/SO diets are only slightly higher than 459 
those quoted by Hites et al.,(11) and considerably lower than those quoted by Easton et al.,(38) 460 
for wild Pacific salmon.  461 
The flesh PBDE concentrations for the fish fed the cNFO, deNFO and SFO/RO/SO diets 462 
were 0.94, 0.25 and 0.10 ng/g, respectively. These values are all significantly lower than the 463 
values recorded for wild Canadian Chinook (4.2) Scottish farmed (3.9) or wild Oregon 464 
Chinook (2.2) by Hites et al.(12) These values were also considerably lower than the average 465 
PBDE concentration of 5 ng/g reported by Jacobs et al.,(45) in 13 samples of European salmon. 466 
Excluding the 9 wild Chinook salmon, the average value for the 36 wild Pacific salmon, 467 
including Pink, Coho, Sockeye and Chum was 0.130 ± 0.020 ng/g(12). The PBDE 468 
concentrations in salmon fed the deNFO and SFO/RO/SO diets were slightly higher and 469 
lower than the wild Pacific salmon, respectively.  470 
There is currently considerable interest in fish, and especially oily fish, as a means of 471 
increasing n-3 HUFA intake in populations that currently have low fish intake. However, 472 
while the benefits of consuming n-3 HUFA are widely known, there is also concern about the 473 
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relative risks and benefits due to the presence of POPs in oily fish(4,14,16,47). The current 474 
guideline of the UK Food Standards Agency (www.food.gov.uk) suggests that we should 475 
consume up to four 140g portions of oily fish per week. However, the FSA add the caveat that 476 
girls and women of child bearing age should only consume two 140g portions of oily fish due 477 
to concerns that POPs present in the fish might pose a risk to the developing foetus. Thus, for 478 
girls or women of child bearing age the FSA recommendation is in a agreement with the EU 479 
Scientific Committee on Food that the maximum intake of PCDD/Fs + DL-PCBs should be 480 
2pg/kg body weight/day(35). However, the FSA guideline suggests that boys, men and women 481 
over reproductive age can consume up to 8pg/kg body weight/day. The salmon fed the cNFO 482 
diet in this study would give 171% of the weekly limit for girls and women of reproductive 483 
age or 86% of the weekly limit value for boys, men and women over reproductive age, from 2 484 
or 4 x 140g portions of cNFO salmon, respectively. However, salmon with these levels of 485 
POPs would not be available for public consumption due to current EU limits on PCDD/Fs 486 
and DL-PCBs in fish feeds(22). In a sample of standard production Scottish salmon analysed in 487 
our laboratory, the average PCDD/F + DL-PCB concentration in 2 x 140g portions was 493 488 
pg TEQ. This represents 47% of the value for girls and women of child bearing age or 24% of 489 
the limit for boys, men and women over reproductive age. By comparison, for the deNFO and 490 
SFO/RO/SO fish, consuming 2 or 4 x 140g portions represents only 9.0 and 10.8% of the 491 
weekly limit for girls and women of reproductive age or 4.5 and 5.4% respectively, of the 492 
weekly limit for PCDD/Fs + DL-PCBs for boys, men and women over reproductive age. 493 
While the POPs concentrations are very low for both the deNFO and SFO/RO/SO salmon, the 494 
same 2 and 4 x 140 g portions provide 147% and 81% and 294% and 162%, respectively, of 495 
the ISSFAL recommended weekly intake of EPA + DHA(8).  496 
In summary, this study has confirmed that FOs with high POP concentrations can be 497 
successfully decontaminated with removal of more than 97% of PCDD/Fs and DL-PCBs 498 
using two stage activated carbon and thin-film deodourisation. Removal of PBDEs was less 499 
successful with concentrations being reduced by around 70%. Feeding the deNFO and 500 
SFO/RO/SO diets to 0.8kg Atlantic salmon for 11 weeks resulted in excellent growth rates 501 
and feed conversion. Flesh PCDD/F and DL-PCB concentrations were reduced to very low 502 
levels in fish fed the deNFO and SFO/RO/SO diets with values being similar to those seen in 503 
wild Pacific salmon while PBDE concentrations were comparable or lower than Pacific 504 
salmon. Feeding the deNFO diet did not significantly alter the n-3 HUFA content of the fillet 505 
as was observed in fish fed the SFO/RO/SO diet. This suggests that decontaminated fish oils 506 
can be used successfully to produce salmon that are both high in n-3 HUFA and low in POPs 507 
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although further longer term trials should be conducted to ensure that no detrimental effects 508 
on fish performance and health occur. These results could be of significant benefit in 509 
producing highly nutritious farmed salmon that are very low in undesirables as well as 510 
utilising valuable FOs that would otherwise be destroyed by incineration.  511 
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Figure legends 674 
Figure 1. Concentrations (% of total fatty acids) of 18:2n-6, 18:3n-3, 20:5n-3 and 22:6n-3 in 675 
flesh of salmon fed either northern fish oil (cNFO), decontaminated northern fish oil (deNFO) 676 
or a blend of southern fish oil, rapeseed and soybean oil (SFO/RO/SO) for 11 weeks. 677 
Columns assigned a different letter are significantly different (P < 0.05).  678 
Figure 2. Amount of dioxin + DL-PCBs present in 2 or 4 x 140g portions of salmon, produced 679 
using cNFO, deNFO or SFO/RO/SO diets. Upper dotted line indicates UK FSA maximum 680 
dioxin/PCB intake of 56 pg/kg/week for a 75kg person while the lower dashed line is the UK 681 
FSA maximum intake of 14 pg/kg/week for a 75kg girl or woman of reproductive age. 682 
Figure 3. Amount of EPA + DHA provided by 2 or 4 x 140g portions of salmon, produced 683 
using cNFO, deNFO or SFO/RO/SO diets. Dotted line indicates ISSFAL recommended EPA 684 
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Table 1. Diet formulations, proximate compositions (g/kg), energy (kJ/g) and major fatty acid 702 
compositions (% of total fatty acids) of the three experimental diets fed to Atlantic salmon for 703 
11 weeks. 704 
Component/Diet                    cNFO                      deNFO                   SFO/RO/SO 705 
Fish meals                               378                          378                              378 706 
Legume meals                         149                          149                              149 707 
Northern fish oil (NFO)          325                            -                                   - 708 
Decontaminated NFO                -                            325                                 - 709 
Southern fish oil                        -                               -                                130 710 
Rapeseed oil                               -                               -                                 98 711 
Soybean oil                                 -                               -                                 98 712 
Binder                                      140                           140                             140 713 
Premixes                                     9.2                            9.2                               9.2 714 
Composition (g/kg) 715 
Protein                                      326                           322                             328 716 
Oil                                             336                           343                             342 717 
Moisture                                     60                              55                              55 718 
Ash                                             78                              77                              78 719 
Fibre                                           21                              22                              20 720 
Digestible energy (kJ/g)            25.3                           25.3                            25.2 721 
Fatty acid 722 
16:0                                            19.2                           18.8                           13.5 723 
Total saturates1                           27.8                           29.3                           23.1 724 
18:1n-9                                       25.9                           21.6                           29.5 725 
Total monounsaturates2              42.0                           40.0                           36.5 726 
18:2n-6                                         3.8                             4.3                            23.1 727 
Total n-63                                     5.6                              5.9                           23.9 728 
18:3n-3                                         2.7                              2.3                            5.1 729 
20:5n-3                                         6.7                              7.2                            5.2 730 
22:6n-3                                       11.6                            11.4                            4.3 731 
Total n-34                                   24.7                            24.7                           16.5 732 
 733 
 25 
cNFO, northern fish oil; deNFO, decontaminated northern fish oil; SFO/RO/SO, southern fish 734 
oil, rapeseed oil and soybean oil. 1Includes 14:0, 15:0, 18:0, 20:0 and 22:0. 2Includes 16:1n-7, 735 
16:1n-9, 20:1n-11, 20:1n-7, 18:1n-7, 20:1n-9, 22:1n-11, 22:1n-9 and 24:1n-9. 3 Includes 736 




Table 2. Dietary concentrations (ng TEQ/kg wet weight) of dioxin and DL-PCB congeners in 741 
the northern fish oil, decontaminated northern fish oil and southern fish oil, rapeseed oil and 742 
soybean oil diets. 743 
Congener/Diet                       cNFO                   deNFO                 SFO/RO/SO 744 
1234678-HpCDD                  0.005                     0.001                        0.001 745 
123478-HxCDD                    0.028                     0.009                        0.007 746 
123678-HxCDD                    0.113                     0.013                        0.012 747 
12378-PeCDD                       1.386                     0.081                        0.038   748 
123789-HxCDD                    0.028                     0.007                        0.010 749 
2378-TCDD                           0.609                     0.040                        0.082 750 
Sum PCDD                           2.169                     0.153                        0.151 751 
 752 
1234678-HpCDF                   0.002                       nd                             nd 753 
123478-HxCDF                     0.084                     0.013                        0.005 754 
1234789-HxCDF                   0.001                       nd                           0.001 755 
123678-HxCDF                     0.102                     0.006                        0.005 756 
12378-PeCDF                        0.147                     0.006                        0.002 757 
123789-HxCDF                     0.018                     0.012                        0.009 758 
234678-HxCDF                     0.125                     0.008                        0.008 759 
23478-PeCDF                        4.775                     0.058                        0.050 760 
2378-TCDF                            1.223                     0.011                        0.015 761 
Sum PCDF                            6.477                     0.114                        0.094 762 
 763 
PCB 105                                 0.355                     0.004                        0.007 764 
PCB 114                                 0.081                     0.002                        0.001 765 
PCB 118                                 1.043                     0.010                        0.014 766 
PCB 123                                 0.010                     0.001                          nd 767 
 26 
PCB 156                                 0.612                     0.029                        0.012 768 
PCB 157                                 0.153                     0.008                        0.002 769 
PCB 167                                 0.005                       nd                             nd 770 
PCB 189                                 0.010                     0.003                          nd 771 
Sum mono-ortho PCB          2.269                     0.057                        0.036 772 
 773 
PCB 77                                   0.001                     0.001                         0.001 774 
PCB 81                                   0.020                       nd                              nd 775 
PCB 126                                 6.4                         0.12                           0.25 776 
PCB 169                                 0.070                     0.007                         0.003 777 
Sum non-ortho PCB             6.4                         0.12                           0.25 778 
 779 
Sum dioxins + PCBs           17.4                         0.45                           0.53 780 
_____________________________________________________________________ 781 
cNFO, northern fish oil; deNFO, decontaminated northern fish oil; SFO/RO/SO, southern fish 782 
oil, rapeseed oil and soybean oil. nd = not detected. 783 
 784 
 785 
Table 3. Dietary concentrations (ng/g wet weight) of seven PBDE congeners in the northern 786 
fish oil, decontaminated northern fish oil and southern fish oil, rapeseed oil and soybean oil 787 
diets. 788 
PBDE                         cNFO                       deNFO                        SFO/RO/SO 789 
PBDE 28                     0.22                          0.013                                 nd 790 
PBDE 47                     3.6                            0.87                                 0.23 791 
PBDE 99                     0.84                          0.34                                 0.027 792 
PBDE 100                   0.89                          0.45                                 0.059 793 
PBDE 153                   0.27                          0.17                                   nd 794 
PBDE 154                   0.15                          0.095                                 nd 795 
PBDE 183                    nd                              nd                                    nd 796 
 797 
Sum PBDE 7              5.94                          1.90                                   0.31 798 
_____________________________________________________________________ 799 
cNFO, northern fish oil; deNFO, decontaminated northern fish oil; SFO/RO/SO, southern fish 800 
oil, rapeseed oil and soybean oil. nd = not detected. 801 
